Page last updated: 2024-10-25

cimetidine and Hyperparathyroidism, Primary

cimetidine has been researched along with Hyperparathyroidism, Primary in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ming-Kai, C1
Ting, Z1

Other Studies

1 other study available for cimetidine and Hyperparathyroidism, Primary

ArticleYear
Primary hyperparathyroidism presenting as intractable nausea and vomiting.
    Southern medical journal, 2010, Volume: 103, Issue:11

    Topics: Aged; Cimetidine; Female; Histamine H2 Antagonists; Humans; Hyperparathyroidism, Primary; Nausea; Vo

2010